Westat reported on Tuesday that it will support clients during the COVID-19 pandemic in a variety of areas, including public health, epidemiologic research and social and economic impact studies to lead to strategies for solutions through contract awards.
The company plans to utilize its research data collection platform established by the Recipient Epidemiology and Donor Evaluation Study IV–Pediatric (REDS-IV-P) Data Coordinating Center to support the National Institute of Allergy and Infectious Diseases, National Heart, Lung and Blood Institute’s research on the epidemiology, surveillance and preparedness of the SARS-CoV-2 epidemic, under the RESPONSE project.
With the company’s support, the institute will develop a deeper insight into the natural history and pathogenesis of this new virus. Westat will also perform work under the Virtual Network of Health Systems Data and Centers for Disease Control and Prevention (CDC).
With the CDC, Westat will study SARS-COV-2. The VISION project will provide a new understanding of health systems and capture information on populations at high risk for COVID-19.
Westat will work with researchers at the University of Louisville to carry out COVID-19 active viral infection and antibody testing on a stratified random sample of adult residents. The research will help establish the prevalence of infection in the community to support re-opening efforts.
In addition, the company will support the Social and Economic Impact Study. Westat will collaborate with the Stanford University School of Medicine to develop and field a nationally representative survey on the social and economic impact of COVID-19 to help policymakers make accurate decisions that can support families and the economy.
Under the Business Impact Study, Westat will conduct a 3-year study of business owners to assess the impact of COVID-19 on sales and operations. The study will also identify resources needed for rapid recovery once the economy reopens.
Westat provides innovative professional services support to clients in addressing challenges to improve outcomes in health, education, social policy, and transportation. We are dedicated to improving lives through research.